Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Re... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugat... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A randomised, double-blind, placebo-controlled trial with an open-label extension to assess the p... Read More
IPOH, April 15 -- Perak Menteri Besar Datuk Seri Saarani Mohamad said the state government will study whether there is a need to table a supplementary budget following concerns over the escalating Wes... Read More
Mumbai, April 15 -- Continental Controls has postponed the meeting of the Board of Directors which was scheduled to be held on 13 April 2026. The meeting will now be held on 15 April 2026. Published ... Read More
U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528560) titled 'HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology)' on March 26. Bri... Read More
U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07529951) titled 'Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers' on April 08. Brie... Read More